Burden of cancer mortality and differences attributable to demographic aging and risk factors in Argentina, 1986-2011

Pou, Sonia Alejandra; Tumas, Natalia; Coquet, Julia Becaria; Niclis, Camila; Román, María Dolores; Díaz, María del Pilar

doi:10.1590/0102-311x00016616

Cited by 13 publications

(12 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This likely reflects favourable reproductive patterns (i.e., higher parity in the past), and possibly different genetic background in some LA populations, besides advancements in the management of the disease . The higher rates observed in Argentina over the whole period and up to recent years may be due to the wave of European immigrants in that country in the past and to an age‐structure similar to that of high‐income countries, with an advanced epidemiological transition . Nonetheless, breast cancer trends in Argentina started to decline earlier compared to other LA countries.…”

Section: Discussionmentioning

confidence: 99%

“…Prostate cancer mortality rates in LA were higher compared to those of the EU and North America and are predicted to be among the highest worldwide. However, they showed favourable trends for most countries up to 2019, likely due to improvements in treatment, and early diagnosis . Similarly to other cancers, progress on prostate cancer was however smaller than in high‐income areas of the world.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cancer mortality predictions for 2019 in Latin America

Carioli

Bertuccio

Malvezzi

et al. 2019

Intl Journal of Cancer

View full text Add to dashboard Cite

We estimated mortality figures for 2019 in seven Latin American countries, with focus on breast cancer. We retrieved cancer death certification and population data from the WHO and PAHO databases. We obtained mortality statistics for Argentina, Brazil, Chile, Colombia, Cuba, Mexico and Venezuela for 1970-2015. We predicted current death numbers and agestandardised (world population) mortality rates using joinpoint regression models. Total cancer mortality is predicted to decline in all countries and both sexes, except Argentinian women. Cuba had the highest all cancer rates for 2019, 136.9/100,000 men and 90.4 women, while Mexico showed the lowest ones, 63.8/100,000 men and 61.9 women. Stomach cancer showed favourable trends over the whole period, while colorectal cancer only recently. Lung cancer rates declined in men, while in women they decreased slightly over the most recent years, only. In Cuban women, lung cancer rates overtook breast cancer ones. Breast cancer showed overall favourable trends, but rates are rising in young women. Prostate and uterine cancer had favourable trends. Pancreas, ovary, bladder and leukaemias showed slightly decreasing trends. Between 1990 and 2019, mortality from all neoplasms is predicted to fall by about 18% in Argentina, 26% in Chile, 14% in Colombia, 17% in Mexico and 13% in Venezuela, corresponding to almost 0.5 million avoided cancer deaths. No decline was observed in Brazil and Cuba. Of concern, the persisting high rates of (cervix) uterus cancer, the high lung cancer rates in Cuba, the possible increases in breast cancer in young women, and the lack of overall declines in Brazil, Cuba and Venezuelan men. Materials and MethodsWe obtained official deaths certification data from the World Health Organization (WHO) database 10 for all cancers combined and for 10 major cancer types, i.e., stomach, colorectum, pancreas, lung, breast, uterus (cervix and corpus), ovary, prostate, bladder and leukaemias. We retrieved data for the period between 1970 and 2015 for LA countries with over Additional Supporting Information may be found in the online version of this article.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Cancer mortality predictions for 2019 in Latin America

Carioli

Bertuccio

Malvezzi

et al. 2019

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Health systems in many nations will require reforms to meet this demand based on the health impact of population ageing. Previous studies have explored specific aspects of the health impact of population ageing and provided policy-makers and researchers with some valuable information [3][4][5][6][7][8]. As an example, Moran et al projected that cardiovascular events will increase by more than 50% between 2010 and 2030 in China as the result of population ageing and population growth [8].…”

Section: Introductionmentioning

confidence: 99%

“…As an example, Moran et al projected that cardiovascular events will increase by more than 50% between 2010 and 2030 in China as the result of population ageing and population growth [8]. However, most studies either focused on selected geographical locations (e.g., United States [9,10] or England and Wales [11,12]), making their conclusions not generalizable, or focused on selected diseases (e.g., coronary heart disease [8,11,13] or cancer [4,14]). Some studies did not separate the effects of population ageing (typically approximated as changes in age structure [3,4]) from those of population growth [8].…”

Section: Introductionmentioning

confidence: 99%

Population ageing and mortality during 1990–2017: A global decomposition analysis

et al. 2020

View full text Add to dashboard Cite

Background As the number of older people globally increases, health systems need to be reformed to meet the growing need for medical resources. A few previous studies reported varying health impacts of population ageing, but they focused only on limited countries and diseases. We comprehensively quantify the impact of population ageing on mortality for 195 countries/territories and 169 causes of death. Methods and findings Using data from the Global Burden of Disease Study 2017 (GBD 2017), this study derived the total number of deaths and population size for each year from 1990 to 2017. A decomposition method was used to attribute changes in total deaths to population growth, population ageing, and mortality change between 1990 and each subsequent year from 1991 through 2017, for 195 countries/territories and for countries grouped by World Bank economic development level. For countries with increases in deaths related to population ageing, we calculated the ratio of deaths attributed to mortality change to those attributed to population ageing. The proportion of people aged 65 years and older increased globally from 6.1% to 8.8%, and the number of global deaths increased by 9 million, between 1990 and 2017. Compared to 1990, 12 million additional global deaths in 2017 were associated with population ageing, corresponding to 27.9% of total global deaths. Population ageing was associated with increases in deaths in high-, upper-middle-, and lower-middle-income countries but not in low-income countries. The proportions of deaths attributed to population ageing in 195 countries/territories ranged from −43.9% to 117.4% for males and −30.1% to 153.5% for females. The 2 largest contributions of population ageing to disease-specific deaths globally between 1990 and 2017 were for ischemic heart disease (3.2 million) and stroke

show abstract

“…Neoplasms are one of the leading causes of morbidity and mortality worldwide 16,18 . Malignant tumors mortality peaked in the late 1980s in Europe and thereafter has declined 19 .…”

Section: Discussionmentioning

confidence: 99%

Long-term trends of potential years of life lost due to main causes of death in the Slovak population, 2004-2013

et al. 2020

View full text Add to dashboard Cite

The aim of this study was to evaluate trends of potential years of life lost (PYLL) rates in the Slovak population and analyze the average annual percent change (AAPC) of PYLL rates regarding the most common causes of death between 2004 and 2013. National mortality and demographic data were obtained from the Statistical Office of the Slovak Republic, and 378,535 causes of death within the period were analyzed. The PYLL values in both genders and each disease category were added up across all age groups to form annual values. For the trend analysis, the AAPC indicator was proposed. The PYLL rate is age-standardized and expressed as a sum of all deaths per 100,000. In the period 2004-2013, the highest mean PYLL rates were observed in neoplasms in the whole population (2,103 per 100,000), as well as in females (2,088 per 100,000), with a permanent high significant increase of AAPC of PYLL in both genders. The second highest mean PYLL rate in the ten-year period was related to circulatory system diseases in total (1,922 per 100,000) as well as in females (1,449 per 100,000). In males, circulatory system diseases had the highest PYLL rate (2,397 per 100,000). The PYLL rates trend regarding external causes of morbidity and mortality showed the most notable decrease in the assessed period and the AAPC of PYLL showed significant negative values both in males (-2.5%; p < 0.001) and females (-4%; p < 0.001). Our results should contribute in developing intervention programs aimed at reducing the burden of premature mortality since the main causes of premature death are associated to well-known and preventable risk factors.

show abstract

Burden of cancer mortality and differences attributable to demographic aging and risk factors in Argentina, 1986-2011

Cited by 13 publications

References 25 publications

Cancer mortality predictions for 2019 in Latin America

Cancer mortality predictions for 2019 in Latin America

Population ageing and mortality during 1990–2017: A global decomposition analysis

Long-term trends of potential years of life lost due to main causes of death in the Slovak population, 2004-2013

Contact Info

Product

Resources

About